Table 1. Signalment, clinical findings and results from blood tests in clonality-positive and clonality-negative Shiba dogs.
| Clonality-positive group (n=13) | Clonality-negative group (n=9) | P | ||
|---|---|---|---|---|
| Signalment | ||||
| Gender, M: MC: F: FS | 6: 3: 3: 1 | 3: 1: 3: 2 | ND | |
| Male: Female ratio | 2.3: 1 | 0.8: 1 | 0.4706 | |
| Age (years) | 6.0 (4.4–8.2) | 6.7 (1.3–11.4) | 0.1009 | |
| Clinical findings | ||||
| Duration of clinical history (months) | 6 (1–48) | 5 (1–24) | 0.7111 | |
| CIBDAI | 8 (2–13) | 7 (4–13) | 0.7113 | |
| CCECAI | 8 (2–17) | 10 (5–14) | 0.4015 | |
| CBC | ||||
| PCV (%) | 40 (29–42) | 37 (23–52) | 0.7372 | |
| WBC (/µl) | 12,200 (2,500–40,500) | 18,400 (12,500–39,400) | 0.0663 | |
| Plt (/µl) | 381,000 (24,000–970,000) | 357,000 (185,000–843,000) | 0.9202 | |
| Serum biochemistry | ||||
| TP (g/dl) | 5.0 (2.8–8.0) | 4.6 (2.6–7.0) | 0.4221 | |
| Alb (g/dl) | 2.0 (1.1–3.4) | 1.9 (1.2–2.5) | 0.482 | |
| BUN (mg/dl) | 13.0 (3.9–37.7) | 14.3 (8.9–27.9) | 0.1814 | |
| Cre (mg/dl) | 0.5 (0.1–1.4) | 0.5 (0.2–1.3) | 0.6129 | |
| ALP (U/l) | 252 (55–2,673) | 151 (70–3,154) | 0.4037 | |
| ALT (U/l) | 115 (20–733) | 75 (19–724) | 0.3673 | |
Data are shown as median (range). M, male; MC, male castrated; F, female; FS, female spayed; ND, not determined.